| PI3K/AKT activation | R-HSA-198203 | 6.32 |
| Immune System | R-HSA-168256 | 2.37 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 7.05 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 4.62 |
| Downstream signal transduction | R-HSA-186763 | 4.65 |
| GAB1 signalosome | R-HSA-180292 | 6.31 |
| Signaling by ERBB4 | R-HSA-1236394 | 4.7 |
| Adaptive Immune System | R-HSA-1280218 | 3.19 |
| Disease | R-HSA-1643685 | 3.33 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 4.95 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 4.71 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 6.37 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 6.37 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 6.37 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 5.59 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 4.71 |
| Signaling by FGFR4 | R-HSA-5654743 | 4.69 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 4.7 |
| Signaling by FGFR | R-HSA-190236 | 4.67 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 6.56 |
| Diseases of signal transduction | R-HSA-5663202 | 4.89 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 4.03 |
| Innate Immune System | R-HSA-168249 | 3.17 |
| Signaling by SCF-KIT | R-HSA-1433557 | 4.73 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 6.37 |
| Signaling by PDGF | R-HSA-186797 | 4.53 |
| DAP12 signaling | R-HSA-2424491 | 4.64 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 6.37 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 4.71 |
| Signaling by EGFR | R-HSA-177929 | 4.59 |
| NGF signalling via TRKA from the plasma membrane | R-HSA-187037 | 4.51 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 5.6 |
| Signalling by NGF | R-HSA-166520 | 4.23 |
| Signaling by FGFR2 | R-HSA-5654738 | 4.68 |
| Signaling by FGFR1 | R-HSA-5654736 | 4.69 |
| PI3K events in ERBB4 signaling | R-HSA-1250342 | 6.37 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 6.37 |
| DAP12 interactions | R-HSA-2172127 | 4.56 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 4.71 |
| Signaling by ERBB2 | R-HSA-1227986 | 4.66 |
| Signaling by FGFR3 | R-HSA-5654741 | 4.69 |
| Signal Transduction | R-HSA-162582 | 1.78 |